Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (A1LN34.SA) Q1 2014 Earnings
A1LN34.SA
13
Feb
Confirmed
Q1 1
Q3 2013
Q4 2013
Q1 2014
-3.59
-2.62
-1.64
-0.66
Details
Expected EPS
N/A
Actual EPS
-1.2193589999999999
Surprise EPS
-1.22
Surprise Percent
+∞%
Description
Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.2193589999999999 per share for Q1 2014.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist